Schedule 13D ownership disclosure

Disc Medicine Inc

Common Stock, $0.0001 par value per share · CUSIP: 254604101

Event date: 2025-08-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Atlas Venture Fund X, L.P.Reported CIK 0001628098

    Shares: 1,084,527.00 · Class: 3.1%

  • ATLAS VENTURE ASSOCIATES X, L.P.Reported CIK 0001742766

    Shares: 1,084,527.00 · Class: 3.1%

  • Atlas Venture Associates X, LLCReported CIK 0001742765

    Shares: 1,084,527.00 · Class: 3.1%

  • Atlas Venture Fund XII, L.P.Reported CIK 0001812049

    Shares: 51,000.00 · Class: 0.1%

  • Atlas Venture Associates XII, L.P.Reported CIK 0001845875

    Shares: 51,000.00 · Class: 0.1%

  • Atlas Venture Associates XII, LLCReported CIK 0001845871

    Shares: 51,000.00 · Class: 0.1%

  • Atlas Venture Opportunity Fund I, L.P.Reported CIK 0001759241

    Shares: 592,908.00 · Class: 1.7%

  • Atlas Venture Associates Opportunity I, L.P.Reported CIK 0001780065

    Shares: 592,908.00 · Class: 1.7%

  • Atlas Venture Associates Opportunity I, LLCReported CIK 0001780066

    Shares: 592,908.00 · Class: 1.7%

  • Atlas Venture Opportunity Fund II, L.P.Reported CIK 0001885327

    Shares: 420,549.00 · Class: 1.2%

  • Atlas Venture Associates Opportunity II, LPReported CIK 0001935814

    Shares: 420,549.00 · Class: 1.2%

  • Atlas Venture Associates Opportunity II, LLCReported CIK 0001935810

    Shares: 420,549.00 · Class: 1.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022121
Form type
SCHEDULE 13D/A
Filer
Atlas Venture Fund X, L.P.
CIK
CIK 1628098
Filed
Aug 15, 2025
Reporting period
Aug 13, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub